Covance Closes Acquisition of Merck Gene Expression Group

Aug 19, 2009

NEW YORK (GenomeWeb News) – Clinical research and pharmaceutical services firm Covance said yesterday that it has closed its acquisition of Merck's Seattle-based gene expression lab.

The financial terms of the purchase, announced last month, were not disclosed, but Merck has agreed to purchase of a five-year genomic analysis services contract worth $145 million as part of the deal.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Drive Away the Flies

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

Fewer Transfusions Needed

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

Alteration Here and There to Win

Futurism writes that gene doping could be the next generation of cheating in sports.

This Week in Nature

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.

Featured White Papers

MLPA Assays on the SeqStudio Genetic Analyzer

Optimized NGS Library Preparation with Acoustic Liquid Handling

May

01

Featured Webinar

Analytical Validation of a Liquid Biopsy Assay for High-Sensitivity Molecular Profiling

This webinar will provide an in-depth case study demonstrating how reference standards can be used to develop and validate circulating tumor DNA (ctDNA)-based assays.

May

08

Featured Webinar

Structural Variation Detection by Proximity Ligation from FFPE Tumor Tissue

This webinar will discuss a proximity ligation-based method for studying structural variation in formalin-fixed paraffin-embedded (FFPE) tissue.

Main menu